Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROBERT F KUSHNER

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1346278314
CMS profile
61175
Location
CHICAGO, IL

General Payments · PY2018–2024

$464,363.86

  • Reported across 310 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$80,549.23

71 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $44,778.85 24
Boehringer Ingelheim Pharmaceuticals, Inc. $14,032.90 19
Regeneron Pharmaceuticals, Inc. $11,280.32 17
Currax Pharmaceuticals LLC $8,810.39 7
Eli Lilly and Company $900.00 1
Novo Nordisk AS $724.11 2
Lilly USA, LLC $22.66 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $64,243.67 31
PY2019 $125,005.06 60
PY2020 $29,465.55 42
PY2021 $35,596.95 30
PY2022 $58,331.17 36
PY2023 $71,172.23 40
PY2024 $80,549.23 71

Payment records · PY2024 (71)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Boehringer Ingelheim Pharmaceuticals, Inc. $487.86 02/01/2024 Travel and Lodging Undisputed 01/23/2026 1117972217 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $85.35 02/29/2024 Travel and Lodging Undisputed 01/23/2026 1117972203 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $212.40 03/11/2024 Travel and Lodging Undisputed 01/23/2026 1117972211 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.00 04/05/2024 Food and Beverage Undisputed 01/23/2026 1117972193 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $140.00 04/05/2024 Travel and Lodging Undisputed 01/23/2026 1117972207 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $6,300.00 04/05/2024 Consulting Fee Undisputed 01/23/2026 1117972221 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $31.98 04/18/2024 Food and Beverage Undisputed 01/23/2026 1117972189 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $31.98 04/18/2024 Food and Beverage Undisputed 01/23/2026 1117972191 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $39.99 04/18/2024 Food and Beverage Undisputed 01/23/2026 1117972199 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $39.99 04/18/2024 Food and Beverage Undisputed 01/23/2026 1117972201 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $100.48 04/18/2024 Food and Beverage Undisputed 01/23/2026 1117972205 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $352.33 04/18/2024 Travel and Lodging Undisputed 01/23/2026 1117972213 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $5,453.07 06/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1117972219 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $370.03 11/19/2024 Travel and Lodging Undisputed 01/23/2026 1117972215 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $31.75 12/05/2024 Food and Beverage Undisputed 01/23/2026 1117972185 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $31.75 12/05/2024 Food and Beverage Undisputed 01/23/2026 1117972187 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $39.68 12/05/2024 Food and Beverage Undisputed 01/23/2026 1117972195 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $39.68 12/05/2024 Food and Beverage Undisputed 01/23/2026 1117972197 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $209.58 12/05/2024 Travel and Lodging Undisputed 01/23/2026 1117972209 CMS
Currax Pharmaceuticals LLC $411.20 07/23/2024 Travel and Lodging Undisputed 01/23/2026 1089514982 CMS
Currax Pharmaceuticals LLC $23.94 07/24/2024 Food and Beverage Undisputed 01/23/2026 1089514974 CMS
Currax Pharmaceuticals LLC $462.64 07/24/2024 Travel and Lodging Undisputed 01/23/2026 1089514976 CMS
Currax Pharmaceuticals LLC $458.61 07/24/2024 Travel and Lodging Undisputed 01/23/2026 1089514984 CMS
Currax Pharmaceuticals LLC $84.00 08/21/2024 Travel and Lodging Undisputed 01/23/2026 1089514978 CMS
Currax Pharmaceuticals LLC $4,370.00 08/21/2024 Consulting Fee Undisputed 01/23/2026 1089514980 CMS
Currax Pharmaceuticals LLC $3,000.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 1089514986 CMS
Eli Lilly and Company $900.00 05/15/2024 Consulting Fee Undisputed 01/23/2026 1135380070 CMS
Lilly USA, LLC $22.66 02/03/2024 Food and Beverage Undisputed 01/23/2026 1135380072 CMS
Novo Nordisk AS $164.11 11/04/2024 Food and Beverage Undisputed 01/23/2026 1096552229 CMS
Novo Nordisk AS $560.00 11/04/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1096552379 CMS
Novo Nordisk Inc $9,000.00 01/01/2024 Consulting Fee Undisputed 01/23/2026 1097389665 CMS
Novo Nordisk Inc $750.00 02/01/2024 Consulting Fee Undisputed 01/23/2026 1097406323 CMS
Novo Nordisk Inc $750.00 02/01/2024 Consulting Fee Undisputed 01/23/2026 1097475851 CMS
Novo Nordisk Inc $750.00 05/07/2024 Consulting Fee Undisputed 01/23/2026 1096861535 CMS
Novo Nordisk Inc $645.22 05/08/2024 Travel and Lodging Undisputed 01/23/2026 1096906569 CMS
Novo Nordisk Inc $358.00 05/08/2024 Travel and Lodging Undisputed 01/23/2026 1097495297 CMS
Novo Nordisk Inc $483.99 05/08/2024 Food and Beverage Undisputed 01/23/2026 1097497621 CMS
Novo Nordisk Inc $521.38 05/08/2024 Travel and Lodging Undisputed 01/23/2026 1097720588 CMS
Novo Nordisk Inc $7,218.75 05/08/2024 Consulting Fee Undisputed 01/23/2026 1097720620 CMS
Novo Nordisk Inc $750.00 08/27/2024 Consulting Fee Undisputed 01/23/2026 1097067994 CMS
Novo Nordisk Inc $750.00 08/27/2024 Consulting Fee Undisputed 01/23/2026 1097772401 CMS
Novo Nordisk Inc $750.00 08/29/2024 Consulting Fee Undisputed 01/23/2026 1096993530 CMS
Novo Nordisk Inc $750.00 08/29/2024 Consulting Fee Undisputed 01/23/2026 1097559618 CMS
Novo Nordisk Inc $750.00 09/03/2024 Consulting Fee Undisputed 01/23/2026 1096577157 CMS
Novo Nordisk Inc $750.00 09/03/2024 Consulting Fee Undisputed 01/23/2026 1097684913 CMS
Novo Nordisk Inc $1,875.00 09/18/2024 Consulting Fee Undisputed 01/23/2026 1097498321 CMS
Novo Nordisk Inc $7,500.00 11/03/2024 Consulting Fee Undisputed 01/23/2026 1097110172 CMS
Novo Nordisk Inc $28.40 11/05/2024 Food and Beverage Undisputed 01/23/2026 1096572610 CMS
Novo Nordisk Inc $1,125.00 11/12/2024 Consulting Fee Undisputed 01/23/2026 1097499036 CMS
Novo Nordisk Inc $508.28 11/13/2024 Food and Beverage Undisputed 01/23/2026 1096887014 CMS
Novo Nordisk Inc $362.19 11/13/2024 Travel and Lodging Undisputed 01/23/2026 1097492421 CMS
Novo Nordisk Inc $530.75 11/13/2024 Travel and Lodging Undisputed 01/23/2026 1097492494 CMS
Novo Nordisk Inc $653.14 11/13/2024 Travel and Lodging Undisputed 01/23/2026 1097492854 CMS
Novo Nordisk Inc $7,218.75 11/13/2024 Consulting Fee Undisputed 01/23/2026 1097838786 CMS
Regeneron Pharmaceuticals, Inc. $341.98 04/28/2024 Travel and Lodging Undisputed 01/23/2026 1143952433 CMS
Regeneron Pharmaceuticals, Inc. $715.00 05/24/2024 Consulting Fee Undisputed 01/23/2026 1114401333 CMS
Regeneron Pharmaceuticals, Inc. $438.14 07/29/2024 Travel and Lodging Undisputed 01/23/2026 1114401335 CMS
Regeneron Pharmaceuticals, Inc. $35.25 07/29/2024 Travel and Lodging Undisputed 01/23/2026 1114401337 CMS
Regeneron Pharmaceuticals, Inc. $536.25 08/14/2024 Consulting Fee Undisputed 01/23/2026 1114401339 CMS
Regeneron Pharmaceuticals, Inc. $183.90 08/25/2024 Food and Beverage Undisputed 01/23/2026 1114401341 CMS
Regeneron Pharmaceuticals, Inc. $149.30 08/26/2024 Travel and Lodging Undisputed 01/23/2026 1114401343 CMS
Regeneron Pharmaceuticals, Inc. $57.75 08/27/2024 Travel and Lodging Undisputed 01/23/2026 1114401345 CMS
Regeneron Pharmaceuticals, Inc. $91.00 08/27/2024 Travel and Lodging Undisputed 01/23/2026 1114401347 CMS
Regeneron Pharmaceuticals, Inc. $7.78 08/29/2024 Food and Beverage Undisputed 01/23/2026 1114401349 CMS
Regeneron Pharmaceuticals, Inc. $29.20 08/29/2024 Food and Beverage Undisputed 01/23/2026 1114401351 CMS
Regeneron Pharmaceuticals, Inc. $16.61 08/29/2024 Food and Beverage Undisputed 01/23/2026 1114401353 CMS
Regeneron Pharmaceuticals, Inc. $32.16 08/29/2024 Food and Beverage Undisputed 01/23/2026 1114401355 CMS
Regeneron Pharmaceuticals, Inc. $1,430.00 10/10/2024 Consulting Fee Undisputed 01/23/2026 1114401357 CMS
Regeneron Pharmaceuticals, Inc. $4,290.00 10/10/2024 Consulting Fee Undisputed 01/23/2026 1114401359 CMS
Regeneron Pharmaceuticals, Inc. $2,860.00 10/10/2024 Consulting Fee Undisputed 01/23/2026 1114401361 CMS
Regeneron Pharmaceuticals, Inc. $66.00 10/10/2024 Travel and Lodging Undisputed 01/23/2026 1114401363 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.